Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$49.7M
+44.3% from 2023
Prescriptions
50K
$1,001.84 per claim
Patients
11K
6,509 prescribers
Total spending, 2024
$49.7M
$4,464.83 per patient
Medicare prescription drug plans paid $49.7M for Verquvo in 2024, for 49,566 prescriptions and refills to 11,123 patients (up 44.3% from 2023). The average cost per claim was $1,001.84.
California had the highest Medicare cost for Verquvo in 2024: $7.1M for 7,098 claims, followed by New York ($6.4M).
Amanda M Brandon, physician assistant in Corbin, KY, had the highest Medicare cost for Verquvo in 2024: 351 claims costing $329K.
Verquvo is made by Merck & Co., Inc. (MRK), listed in the Medicare spending data as Merck Sharp & D.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Amanda M Brandon Corbin, KY | Physician Assistant | 351 | 69 | $329K |
| John T Funai Lihue, HI | Cardiology | 152 | 38 | $211K |
| Siva Arunasalam Victorville, CA |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,954 | 17,215 | 4,688 | $15.7M |
| 2023 | 5,017 | 34,477 | 8,214 | $34.4M |
| 2024 | 6,509 | 49,566 | 11,123 | $49.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Cardiology |
| 175 |
| 35 |
| $208K |
| Shashi K Sharma Visalia, CA | Cardiology | 145 | 31 | $175K |
| Marlon G Ramilo Modesto, CA | Cardiology | 135 | 36 | $173K |
| Claudio Bonometti Las Vegas, NV | Cardiology | 116 | 32 | $167K |
| Irena Pleskova Brooklyn, NY | Internal Medicine | 165 | 32 | $157K |
| Frank T Schwender Bowling Green, KY | Clinical Cardiac Electrophysiology | 161 | 29 | $136K |
| Ernest D Afflu Brooklyn, NY | Cardiology | 120 | 21 | $130K |
| George Juang Flushing, NY | Clinical Cardiac Electrophysiology | 138 | 27 | $128K |
| Henock Saint-Jacques New York, NY | Cardiology | 85 | 24 | $124K |
| Anna Kezerashvili Bronx, NY | Cardiology | 120 | 18 | $119K |
| Weiguo Li Alhambra, CA | Family Practice | 159 | 28 | $117K |
| Marc Moreau Amarillo, TX | Interventional Cardiology | 105 | 23 | $116K |
| Kayla M Smith Jackson, MS | Nurse Practitioner | 95 | 25 | $114K |
| Shezad Sanaullah Bluffton, IN | Cardiology | 93 | 36 | $114K |
| Catherine N Marti Athens, GA | Cardiology | 74 | 20 | $110K |
| Ashoka Nautiyal Cleveland, OH | Cardiology | 112 | 20 | $109K |
| Muhammad F Jan Milwaukee, WI | Interventional Cardiology | 75 | 17 | $101K |
| Anna Milstein Los Angeles, CA | Cardiology | 140 | 17 | $100K |
| Gregory F Egnaczyk Cincinnati, OH | Advanced Heart Failure and Transplant Cardiology | 117 | 29 | $99K |
| Khalid Abousy Manassas, VA | Interventional Cardiology | 61 | 20 | $99K |
| Maria Theresa M Espiritu Sebring, FL | Nurse Practitioner | 76 | 25 | $96K |
| Dan V Dang San Jose, CA | Cardiology | 86 | 22 | $96K |
| Mauricio Melhado West Palm Beach, FL | Cardiology | 102 | 19 | $95K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Merck Sharp & D MRK | 49,590 | $49.7M |